In the pharmaceutical industry, Acarbose tablets (typically 25 mg, 50 mg, and 100 mg) are classified as an alpha-glucosidase inhibitor. As a pharmacist, I define Acarbose as a specialized anti-diabetic agent that focuses on the “postprandial” phase—controlling the sharp rise in blood glucose that occurs immediately after eating.
Primary Clinical Uses
Type 2 Diabetes Mellitus: Used as a primary or adjunctive therapy to improve glycemic control in adults with type 2 diabetes.
Postprandial Glucose Management: It is specifically effective for patients who struggle with high blood sugar spikes after carbohydrate-rich meals.
Synergistic Combination Therapy: Frequently used alongside Metformin, Sulfonylureas, or Insulin when a single medication is insufficient to meet HbA1c targets.
Prediabetes Management: In certain clinical contexts, it is used to delay the onset of type 2 diabetes in patients with impaired glucose tolerance (IGT).
Mechanism of Action
Acarbose operates through a non-systemic, local action within the gastrointestinal tract. It competitively inhibits the intestinal enzymes (alpha-glucosidases) responsible for breaking down complex carbohydrates (disaccharides, oligosaccharides, and polysaccharides) into absorbable glucose. By slowing the rate of carbohydrate digestion, it ensures a slower, more gradual rise in blood glucose levels, effectively reducing the workload on the pancreas.
The Manufacturer’s Perspective: Formulation & Export
From a manufacturing and global trade standpoint, Acarbose requires high-precision technical handling:
Moisture Sensitivity: Acarbose is hygroscopic. To ensure a stable shelf-life, we utilize Alu-Alu blister packing and maintain strict humidity controls (RH) during the compression and packaging stages.
Technical Compliance: As a WHO-GMP certified firm, our Acarbose formulations undergo rigorous dissolution testing to ensure the drug release matches the physiological requirements of the small intestine.
Export Logistics: Given the global rise in sedentary lifestyles and high-carb diets, Acarbose is a high-demand molecule for our export partners in Southeast Asia, MENA, and LATAM regions.
B2B Support: We provide comprehensive CTD/eCTD dossiers for international registration, ensuring our partners can quickly enter their local markets with a high-quality product.
Global Keyword & Tag Cluster (Copy-Paste Ready)
Acarbose 50 mg tablets, Acarbose 100 mg manufacturer, alpha-glucosidase inhibitor, postprandial glucose control, type 2 diabetes treatment, Acarbose BP/USP, anti-diabetic export India, WHO-GMP pharma manufacturer, Mumbai pharmaceutical exporter, B2B pharma marketplace, glycemic spike management, diabetes medicine supplier, Acarbose manufacturing process